IFITM3 and Guillain-Barre syndrome, familial: 16 DEGs were screened in CD16 + monocytes, MTRNR2L8 and IFITM3 were elevated in AIDP patients, while HLA-DRB5 and RPS26 were decreased in AIDP patients (Supplementary Fig. S7g).